A Phase II Trial of Combination Capecitabine, Oxaliplatin and Bevacizumab in Treatment of Advanced Hepatocellular Carcinoma (HCC)
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2007
At a glance
- Drugs Bevacizumab; Capecitabine; Oxaliplatin
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Nov 2007 New trial record.